Tianjin Chase Sun Pharmaceutical Co.,Ltd.’s Net Profit Rose 26.3% in First Half of 2021

Tianjin Chase Sun Pharmaceutical Co.,Ltd. (天津红日药业股份有限公司) (300026.SZ) reported a net profit of 430.2 million yuan in the first half of 2021, up 26.3% year-on-year.

Meanwhile, the company posted 3.5 billion yuan in revenue, up 25.3% year-on-year.

At the end of the reporting period, it had 10.5 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 26.8%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.